Related Experiment Video

Updated: Jun 19, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Thrombopoietic cytokines and platelet count in multiple myeloma

Zübeyde Nur Ozkurt1, Münci Yağci, Gülsan Türköz Sucak

  • 1Gazi University, Faculty of Medicine, Department of Hematology, Beşevler, Ankara, Turkey. znozkurt@gazi.edu.tr

Platelets
|November 7, 2009
PubMed

Insights

In multiple myeloma (MM), elevated interleukin-6 (IL-6) and thrombopoietin (TPO) levels correlate with platelet counts. This suggests IL-6 may drive TPO production, maintaining platelet levels despite MM progression.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Interleukin-6 (IL-6) and IL-1beta are cytokines involved in multiple myeloma (MM) pathogenesis and megakaryopoiesis.
  • The interplay between thrombopoiesis and cytokines in MM may influence platelet (PLT) counts.

Purpose of the Study:

  • To investigate the relationship between plasma cytokine levels and platelet counts in patients with multiple myeloma.
  • To explore the correlation between thrombopoietin (TPO), IL-6, and platelet counts in MM.

Main Methods:

  • Plasma levels of TPO, IL-1beta, IL-11, and IL-6 were measured using ELISA in 68 MM patients and 21 controls.
  • Platelet counts were compared between groups, and correlations with cytokine levels were analyzed.

Main Results:

  • Platelet counts did not differ significantly between MM patients and controls.
  • MM patients exhibited higher plasma levels of IL-6 and TPO compared to healthy subjects.
  • Platelet counts showed an inverse correlation with TPO levels and a positive correlation with IL-6 levels in MM patients. TPO and IL-6 levels were significantly correlated.

Conclusions:

  • Elevated IL-6 and TPO levels are characteristic of MM.
  • High TPO levels, potentially induced by IL-6, may help maintain normal platelet counts in MM patients.
  • This mechanism could compensate for bone marrow infiltration and reduced platelet half-life in MM.

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...